Liminatus Pharma Ownership | Who Owns Liminatus Pharma?

Liminatus Pharma Ownership Summary

Liminatus Pharma is owned by 6.21% institutional investors, 38.53% insiders, and 55.26% retail investors.

LIMN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Liminatus Pharma	6.21%	38.53%	55.26%
Sector	Healthcare Stocks	35.38%	11.35%	53.27%
Industry	Biotech Stocks	33.91%	11.39%	54.70%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	15	25.00%	1,475,438	365.15%	6	348.35%	11	83.33%	3	50.00%
Dec 31, 2025	12	20.00%	317,193	21.10%	1	141.98%	6	-	2	100.00%
Sep 30, 2025	10	-	261,924	27.95%	-	125.66%	6	-40.00%	1	-
Jun 30, 2025	10	-	204,702	-	-	-	10	-	-	-

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-

LIMN Ownership FAQ

Who Owns Liminatus Pharma?

Liminatus Pharma shareholders are primarily institutional investors at 6.21%, followed by 38.53% insiders and 55.26% retail investors. The average institutional ownership in Liminatus Pharma's industry, Biotech Stocks , is 33.91%, which Liminatus Pharma falls below.

Does Blackrock own Liminatus Pharma?

BlackRock is not among the top 10 institutional shareholders of Liminatus Pharma.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools